Aetna, the health, medical and benefits insurance unit of CVS Health, has now finalised the details of its sixteenth health and medical benefit claim linked insurance-linked securities (ILS) deal, securing the targeted $250 million of reinsurance from the Vitality Re XVI Ltd (Series 2025) issuance and making it the largest Vitality Re deal yet.
Read the full article
Aetna, the health, medical and benefits insurance unit of CVS Health, is on-track to secure what will be the largest insurance-linked securities (ILS) issuance in its long-standing Vitality Re series, as the firm’s sixteenth transaction continued to target $250 million of reinsurance from the Vitality Re XVI Ltd (Series 2025) deal.
Read the full article
Aetna, the health, medical and benefits insurance unit of CVS Health, is back in the insurance-linked securities (ILS) market and seeking what could become its largest issuance in the long-standing Vitality Re series, as the firm’s sixteenth transaction launches with a target for $250 million of reinsurance from a Vitality Re XVI Ltd (Series 2025) […]
Read the full article
